Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity

Clinical trial NCT00636142 · COMPLETED

Trial details

NCT number: NCT00636142
Sponsor: Medical University of Graz
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Obesity Insulin Resistance Metabolic Syndrome

Start date: 2005-09-01
Primary completion: 2007-06-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.